We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$35.5B
AUM Growth
+$586M
(+1.7%)
Cap. Flow
-$902M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$104M |
| 2 |
Occidental Petroleum
OXY
|
+$86.7M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$82.9M |
| 4 |
Public Storage
PSA
|
+$71.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$418M |
| 2 |
Consolidated Edison
ED
|
+$212M |
| 3 |
Crown Castle
CCI
|
+$103M |
| 4 |
Target
TGT
|
+$93.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.37% |
| 2 | Healthcare | 13.5% |
| 3 | Communication Services | 10.7% |
| 4 | Utilities | 9.74% |
| 5 | Technology | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Teleflex
TFX
$5.96B
| $23.2M | 0.07% |
93,433
+27,464
| +42% | +$6.9M |
|
|
ALXN
227
DELISTED
Alexion Pharmaceuticals
ALXN
| $23.2M | 0.07% |
194,014
-376,034
| -66% | -$45.8M |
|
|
CELG
228
DELISTED
Celgene Corp
CELG
| $22.9M | 0.06% |
218,967
-29
| -0% | -$3.27K |
|
229
Emergent Biosolutions
EBS
$379M
| $22.8M | 0.06% |
490,841
+262,729
| +115% | +$11.1M |
|
230
Costco
COST
$432B
| $22.7M | 0.06% |
121,853
-75,292
| -38% | -$13M |
|
231
CNO Financial Group
CNO
$4.94B
| $22.7M | 0.06% |
918,509
-210,560
| -19% | -$5.14M |
|
232
United Rentals
URI
$65.7B
| $22.7M | 0.06% |
131,836
-20,611
| -14% | -$3.14M |
|
233
Everest Group
EG
$15.6B
| $22.7M | 0.06% |
102,377
-9,056
| -8% | -$2.04M |
|
234
KeyCorp
KEY
$23.8B
| $22.4M | 0.06% |
1,112,724
-94,407
| -8% | -$1.78M |
|
235
Medtronic
MDT
$112B
| $22.1M | 0.06% |
273,195
+106,752
| +64% | +$8.55M |
|
236
Lowe's Companies
LOW
$121B
| $22M | 0.06% |
237,140
-5,365
| -2% | -$444K |
|
237
Spire
SR
$4.79B
| $21.9M | 0.06% |
291,583
+236
| +0.1% | +$18.3K |
|
238
Gilead Sciences
GILD
$165B
| $21.6M | 0.06% |
301,296
+93,682
| +45% | +$7.11M |
|
239
Devon Energy
DVN
$51.3B
| $21.5M | 0.06% |
518,929
+76,398
| +17% | +$2.89M |
|
240
Kennametal
KMT
$2.56B
| $21.4M | 0.06% |
442,576
+90,658
| +26% | +$4.04M |
|
241
Western Digital
WDC
$159B
| $21.3M | 0.06% |
354,613
+322,741
| +1,013% | +$20.8M |
|
242
DuPont de Nemours
DD
$18.6B
| $21.3M | 0.06% |
+118,187
| New | +$21.3M |
|
243
Insight Enterprises
NSIT
$3.85B
| $21.1M | 0.06% |
551,878
+128,230
| +30% | +$5.24M |
|
244
Urban Outfitters
URBN
$6.46B
| $21.1M | 0.06% |
600,991
-38,464
| -6% | -$1.08M |
|
245
Agilent Technologies
A
$39.6B
| $20.9M | 0.06% |
312,639
-673
| -0.2% | -$45.4K |
|
246
Halliburton
HAL
$26.1B
| $20.7M | 0.06% |
424,301
+372,624
| +721% | +$16.4M |
|
247
Novartis
NVS
$302B
| $20.6M | 0.06% |
274,174
+1,618
| +0.6% | +$122K |
|
248
Bristol-Myers Squibb
BMY
$129B
| $20.6M | 0.06% |
335,414
+144,110
| +75% | +$9.01M |
|
249
IDEX
IEX
$17B
| $20.3M | 0.06% |
153,586
+82,901
| +117% | +$10.7M |
|
250
Norfolk Southern
NSC
$75.4B
| $20.2M | 0.06% |
139,362
-110,371
| -44% | -$14.8M |
|
Similar funds
Federated Hermes's Q4 2017 Portfolio in Review
As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.
- Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
- Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
- Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
- Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
- Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
- Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.
Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.